- (a) Specifications. Each milliliter (mL) of suspension contains 25 milligrams (mg) molidustat sodium.
- (b) Sponsor. See No. 058198 in § 510.600(c) of this chapter.
- (c) Conditions of use—(1) Amount. Administer orally at a dosage of 5 mg/kg of body weight (2.3 mg/lb) daily for up to 28 consecutive days.
- (2) Indications for use. For the control of nonregenerative anemia associated with chronic kidney disease in cats.
- (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. It is a violation of Federal law to use this product other than as directed in the labeling.
[88 FR 55563, Aug. 16, 2023]